Current Trials
Find out more about taking part in one of our trials
A randomised, double-blind, placebo controlled, parallel group, multi-centre trial in adult subjects with newly diagnosed type 1 diabetes mellitus investigating the effect of Verapamil SR on preservation of beta-cell function (Ver-A-T1D)
Trial of a new medication in people with 1 diabetes aged 5-25. Screening visit to be conducted within 9 weeks of diagnosis.
Study of safety and efficacy of CFZ533 in children and young adults with new onset type 1 diabetes.
Trial of a new medication in people with 1 diabetes aged 18-44. Screening visit to be conducted within 9 weeks of diagnosis.
Would you like to be involved in studies where you have more monitoring, so that researchers can find out more about type 1 diabetes?
A research project for children and adults aged 1 or older and newly diagnosed with type 1 diabetes (within the last 6 months), to collect information about their diabetes, and inform them about other opportunities to take part in type 1 diabetes research. Siblings can help too.
Can a remotely monitored, home-based exercise intervention for individuals with type-one diabetes reduce immune driven disease activity? (EXTOD-Immune)
Recruitment closed
Remote study investigating the progression of Type 1 diabetes in adults (18 years and over) within 120 days of diagnosis and insulin treated.
Recruitment closed
A project throughout Europe which collects blood samples and data from newly diagnosed patients between 1 and 45 years who have been diagnosed with type 1 diabetes within the previous 6 weeks and their first degree relatives (brothers, sisters, parents or children).
Recruitment closed
The PROTECT Study is testing how well an investigational medicine works in children and adolescents with Type 1 diabetes (T1D).
Recruitment closed
ITAD is a multicentre, randomised, double-blind, placebo-controlled clinical trial of to see if a drug called aldesleukin, can preserve insulin production in children and young adults recently diagnosed with type 1 diabetes.
Recruitment closed
Trial of a new medication in 12-18 year olds with Type 1 diabetes within 100 days of diagnosis
Recruitment closed
The main purpose of this study is to assess the safety of three different doses of an investigational drug in patients who have been recently diagnosed with type 1 diabetes.
Recruitment closed
This study aims to gain a better understanding of the immune processes that lead to the destruction of insulin producing beta cells.
Recruitment closed
This study will investigate if a new drug Anti-IL-21 when given together with another drug marketed for type 2 diabetes called liraglutide can preserve the beta cells in subjects diagnosed with type 1 diabetes.